Evidence map›Paper›PMID 40683658›Full record

ArticleJournal of the American Association for Laboratory Animal Science : JAALAS2025

Animal Research at a Crossroads: Strengths, Weaknesses, Opportunities, and Emerging Threats.

Sally A Thompson-Iritani, Joseph T Newsome

Abstract read
In one paragraph

Article in Journal of the American Association for Laboratory Animal Science : JAALAS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sally A Thompson-Iritani1Animal Care, Outreach, and 3Rs, Office of Research, University of Washington, Seattle, Washington; and.
Joseph T Newsome2Department of Pathology and Division of Laboratory Resources, University of Pittsburgh, Pittsburgh, Pennsylvania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Research involving animals is pivotal to advancing biomedical and veterinary sciences, contributing to discoveries that have saved countless lives and improved global health. However, the field faces increasing scrutiny from ethical, scientific, and societal perspectives. This paper applies a strategic Strengths, Weaknesses, Opportunities, Threats (SWOT) analysis, adapted from traditional business planning, to critically evaluate the current landscape of animal research, offering a balanced perspective on its contributions and challenges. While typically used to assess organizational performance, here the framework is reinterpreted to provide a structured, holistic view of the internal and external factors shaping ethical, scientific, and societal aspects of animal research. Strengths include its foundational role in Nobel Prize-winning discoveries, medical advancements, and therapeutic safety. Key weaknesses, such as public mistrust, ethical concerns, resource limitations, and rigor and reproducibility, are examined. Opportunities lie in the advancement of study refinements, improved methodologies, and fostering stakeholder communication. Threats such as misunderstanding, regulatory complexities, and resource constraints are addressed through strategic recommendations, including investment in Replacement, Reduction, and Refinement (3Rs), effective public engagement, and global harmonization of standards. This paper concludes by presenting an actionable roadmap to ensure the continued ethical and impactful use of animals in research while embracing innovation and maintaining public trust.

Indexed as

3Rs, Replacement, Reduction, and RefinementFDCA, Federal Food, Drug, and Cosmetic ActSWOT, Strengths, Weaknesses, Opportunities, Threats

Identifiers

PMID40683658
PMCPMC12379634

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.